Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension

BACKGROUND: The evidence regarding triple oral combination therapy for patients with pulmonary arterial hypertension (PAH) is scarce. This study was performed to investigate the effectiveness and safety of triple oral combination therapy with macitentan, riociguat, and selexipag. METHODS: Among cons...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ther Adv Respir Dis
Prif Awduron: Momoi, Mizuki, Hiraide, Takahiro, Shinya, Yoshiki, Momota, Hiromi, Fukui, Shogo, Kawakami, Michiyuki, Itabashi, Yuji, Fukuda, Keiichi, Kataoka, Masaharu
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2021
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919213/
https://ncbi.nlm.nih.gov/pubmed/33627044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466621995048
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg